Obesity in Pakistan

From WikiMD's WELLNESSPEDIA


Pakistan, officially known as the Islamic Republic of Pakistan, is a country located in South Asia. It is the world's fifth-most populous country with a population exceeding 212.2 million. In terms of area, it is the 33rd-largest country, spanning 881,913 square kilometres (340,509 square miles).

In 2016, Pakistan had an adult obesity rate of 8.6%, ranking it 148th globally. Obesity is a growing health concern in Pakistan with health officials stating that it is one of the leading causes of preventable deaths in Pakistan.

Obesity in Pakistan[edit]

Obesity in Pakistan is a health issue that has effected only a small proportion of the population, but is growing at a rapid pace. The increase in obesity has led to a rise in related health problems such as diabetes, heart disease, and hypertension.

Healthcare Facilities[edit]

There are several well-known healthcare facilities in Pakistan that offer weight loss programs and treatments. These include:

  • Aga Khan University Hospital - Offers a comprehensive weight management program that includes diet, exercise, and behavioral therapy.
  • Shifa International Hospital - Provides a multidisciplinary approach to weight loss with services that include nutrition counseling, physical therapy, and surgical options.
  • Liaquat National Hospital - Offers a range of services for weight loss including bariatric surgery and lifestyle modification programs.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.